Emerging therapies for adult soft tissue sarcoma

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Expert Review of Anticancer Therapy

• Publication date

  2014-05-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1586/14737140.2014.885840PMID 24555529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 3403 Final overall survival (OS) analysis of the randomized phase 3 study of trabectedin (T) or dacarbazine (D) for the treatment of patients (pts) with advanced leiomyosarcoma (LMS) or liposarcoma (LPS)

  2015cited by this paper
• GeDDiS: A prospective randomised controlled phase III trial of gemcitabine and docetaxel compared with doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft tissue sarcomas (EudraCT 2009-014907-29).

  2015cited by this paper
• Mode of action of trabectedin in myxoid liposarcomas

  2014influential reference
• Pazopanib a tyrosine kinase inhibitor with strong anti-angiogenetic activity: a new treatment for metastatic soft tissue sarcoma.

  2014cited by this paper
• Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.

  2013cited by this paper
• Results of an international randomized phase III trial of the mammalian target of rapamycin inhibitor ridaforolimus versus placebo to control metastatic sarcomas in patients after benefit from prior chemotherapy.

  2013cited by this paper
• The Impact of Bevacizumab (Avastin) on Survival in Metastatic Solid Tumors - A Meta-Analysis and Systematic Review

  2013cited by this paper
• Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience

  2013cited by this paper
• New targeted therapies in melanoma.

  2013cited by this paper
• Malignant Perivascular Epithelioid Cell Neoplasm (PEComa) of the Urinary Bladder With TFE3 Gene Rearrangement: Clinicopathologic, Immunohistochemical, and Molecular Features

  2013cited by this paper
• Dermatofibrosarcoma protuberans (DFSP) successfully treated with sorafenib: case report

  2013cited by this paper
• Ridaforolimus in advanced or metastatic soft tissue and bone sarcomas

  2013cited by this paper
• Endometrial Stromal Sarcoma: A Systematic Review

  2013cited by this paper
• Gemcitabine and Docetaxel for Metastatic Soft Tissue Sarcoma - a Single Center Experience

  2013cited by this paper
• A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group

  2013cited by this paper
• The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.

  2013cited by this paper
• Insulin-Like Growth Factor 1 Receptor as a Therapeutic Target in Ewing Sarcoma: Lack of Consistent Upregulation or Recurrent Mutation and a Review of the Clinical Trial Literature

  2013cited by this paper
• Trabectedin in the Neoadjuvant Treatment of High-Grade Pleomorphic Sarcoma: Report of a Rare Case and Literature Review

  2013cited by this paper
• An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas.

  2013cited by this paper
• Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO)

  2013influential reference
• Clinical outcomes and safety with trabectedin therapy in patients with advanced soft tissue sarcomas following failure of prior chemotherapy: results of a worldwide expanded access program study.

  2013cited by this paper
• WHO classification of tumours of soft tissue and bone

  2013cited by this paper
• Phase I trial of concurrent sunitinib and radiation therapy as preoperative treatment for soft tissue sarcoma

  2013cited by this paper
• Clinical activity of sunitinib in patients with advanced desmoplastic round cell tumor: a case series

  2013cited by this paper
• Dacarbazine in Solitary Fibrous Tumor: A Case Series Analysis and Preclinical Evidence vis-à-vis Temozolomide and Antiangiogenics

  2013cited by this paper
• Combination therapy for scalp angiosarcoma using bevacizumab and chemotherapy: a case report and review of literature.

  2013cited by this paper
• Factors influencing survival in metastatic synovial sarcoma: importance of patterns of metastases and the first-line chemotherapy regimen

  2013cited by this paper
• Current Phase II clinical data for ridaforolimus in cancer

  2013cited by this paper
• Myxoid liposarcoma and the mammalian target of rapamycin pathway

  2013cited by this paper
• Leiomyosarcoma.

  2013cited by this paper
• Adjuvant Therapy for High-Risk Soft Tissue Sarcoma in the Adult

  2013cited by this paper
• LMS-02: A phase II single-arm multicenter study of doxorubicin in combination with trabectedin as a first-line treatment of advanced uterine leiomyosarcoma (u-LMS) and soft tissue LMS (ST-LMS): First results in patients with u-LMS.

  2013cited by this paper
• Cediranib for metastatic alveolar soft part sarcoma.

  2013cited by this paper
• Emerging therapies for soft-tissue sarcomas.

  2013influential reference
• Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma?

  2013cited by this paper
• Multicenter phase II study of everolimus in patients with metastatic or recurrent bone and soft-tissue sarcomas after failure of anthracycline and ifosfamide

  2013cited by this paper
• Targeted treatment for advanced soft tissue sarcoma: profile of pazopanib

  2013cited by this paper
• Trabectedin in metastatic soft tissue sarcomas: Role of pretreatment and age

  2013cited by this paper
• Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

  2013cited by this paper
• Pazopanib in sarcomas: expanding the PALETTE

  2013cited by this paper
• The Role of Radiation in Retroperitoneal Sarcomas

  2013cited by this paper
• Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall.

  2013cited by this paper
• Novel Pathways and Molecular Targets for the Treatment of Sarcoma

  2013cited by this paper
• Response to chemotherapy of solitary fibrous tumour: a retrospective study.

  2013cited by this paper
• Chemotherapy for the treatment of malignant peripheral nerve sheath tumors in neurofibromatosis 1: a 10-year institutional review

  2013influential reference
• Targeted Therapies in Sarcomas: Challenging the Challenge

  2012cited by this paper
• Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2012cited by this paper
• Pathologic complete response of a malignant peripheral nerve sheath tumor in the lung treated with neoadjuvant Ifosfamide and radiation therapy.

  2012cited by this paper
• Chemotherapy treatment patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study.

  2012cited by this paper
• Clinical Phase I/II trial to Investigate Preoperative Dose-Escalated Intensity-Modulated Radiation Therapy (IMRT) and Intraoperative Radiation Therapy (IORT) in patients with retroperitoneal soft tissue sarcoma: interim analysis

  2012cited by this paper
• Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial.

  2012cited by this paper
• Sunitinib malate in solitary fibrous tumor (SFT).

  2012cited by this paper
• Hedgehog and Notch signaling regulate self-renewal of undifferentiated pleomorphic sarcomas.

  2012cited by this paper
• The Molecular Biology of Soft-Tissue Sarcomas and Current Trends in Therapy

  2012cited by this paper
• Pazopanib for the treatment of soft-tissue sarcoma

  2012cited by this paper
• Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2012cited by this paper
• Objective response to sorafenib in advanced clear-cell sarcoma.

  2012cited by this paper
• Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis

  2012cited by this paper
• Randomized multicenter and stratified phase II study of gemcitabine alone versus gemcitabine and docetaxel in patients with metastatic or relapsed leiomyosarcomas: a Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC) French Sarcoma Group Study (TAXOGEM study).

  2012cited by this paper
• Gemcitabine in advanced angiosarcoma: a retrospective case series analysis from the Italian Rare Cancer Network.

  2012cited by this paper
• Efficacy and toxicity of gemcitabine plus docetaxel combination as a second line therapy for patients with advanced stage soft tissue sarcoma.

  2012cited by this paper
• Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

  2012cited by this paper
• Pazopanib in the treatment of soft tissue sarcoma

  2012cited by this paper
• A phase II evaluation of trabectedin in the treatment of advanced, persistent, or recurrent uterine leiomyosarcoma: a gynecologic oncology group study.

  2012cited by this paper
• Cediranib: a VEGF receptor tyrosine kinase inhibitor.

  2012cited by this paper
• Prevailing importance of the hedgehog signaling pathway and the potential for treatment advancement in sarcoma.

  2012cited by this paper
• Frontline extended surgery is associated with improved survival in retroperitoneal low- to intermediate-grade soft tissue sarcomas.

  2012cited by this paper
• Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO).

  2012cited by this paper
• Extraskeletal myxoid chondrosarcoma: tumor response to sunitinib

  2012cited by this paper
• Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.

  2012cited by this paper
• Surgery in soft tissue sarcoma: more conservative in extremities, more extended in the retroperitoneum

  2012cited by this paper
• Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis

  2012cited by this paper
• [Oligometastatic disease, a new concept: stereotactic irradiation for lung metastases. Literature review].

  2012cited by this paper
• Phase 2 Southwest Oncology Group‐directed intergroup trial (S0505) of sorafenib in advanced soft tissue sarcomas

  2012cited by this paper
• Notch, Wnt, and Hedgehog Pathways in Rhabdomyosarcoma: From Single Pathways to an Integrated Network

  2012cited by this paper
• Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

  2012cited by this paper
• Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors.

  2012cited by this paper
• Pulmonary metastasectomy for soft tissue sarcoma.

  2012cited by this paper
• Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study.

  2012cited by this paper
• Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non–Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study

  2012cited by this paper
• Histology- and non-histology-driven therapy for treatment of soft tissue sarcomas.

  2012cited by this paper
• Durable clinical activity of single-agent bevacizumab in a nonagenarian patient with metastatic alveolar soft part sarcoma.

  2012cited by this paper
• Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma.

  2012cited by this paper
• A Clinical phase I/II trial to investigate preoperative dose-escalated intensity-modulated radiation therapy (IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal soft tissue sarcoma

  2012cited by this paper
• Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas.

  2012cited by this paper
• Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas

  2012cited by this paper
• Treatment outcome of conservative surgery plus postoperative radiotherapy for extremity soft tissue sarcoma

  2012cited by this paper
• The Epidemiology of Sarcoma

  2012cited by this paper
• New Therapeutic Targets in Soft Tissue Sarcoma

  2012cited by this paper
• Imatinib Mesylate

  2012cited by this paper
• Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group.

  2012cited by this paper
• Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.

  2011cited by this paper
• Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect.

  2011cited by this paper
• Trabectedin: Safety and Efficacy in the Treatment of Advanced Sarcoma

  2011cited by this paper
• The diagnosis and treatment of soft tissue sarcomas of the limbs.

  2011cited by this paper
• Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes.

  2011cited by this paper
• Trabectedin in advanced uterine leiomyosarcomas: a retrospective case series analysis from two reference centers.

  2011cited by this paper
• Advances in sarcoma genomics and new therapeutic targets

  2011cited by this paper
• [Diagnosis and treatment of epithelioid sarcoma].

  2011cited by this paper
• High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients

  2011cited by this paper

• Chondrosarcoma: Multi-Targeting Therapeutic Effects of Doxorubicin, BEZ235, and the Small Molecule Aspartyl-Asparaginyl-β-hydroxylase Inhibitor SMI1182

  2025cites this paper
• Synovial sarcoma: the misdiagnosed sarcoma

  2024cites this paper
• UK guidelines for the management of soft tissue sarcomas

  2024cites this paper
• Progress in histology specific treatments in soft tissue sarcoma

  2024cites this paper
• A machine learning-based model for clinical prediction of distal metastasis in chondrosarcoma: a multicenter, retrospective study

  2023cites this paper
• Retroperitoneal Sarcomas: Histology Is Everything.

  2022cites this paper
• Primary gastric dedifferentiated liposarcoma resected endoscopically: A case report

  2022cites this paper
• Synovial Sarcoma of the Extremities: A Literature Review

  2021cites this paper
• Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans

  2021cites this paper
• Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group

  2021cites this paper
• Effect of anthracyclines/ifosfamide-based adjuvant chemotherapy for soft tissue sarcoma: a conventional and network Meta-analysis

  2021cites this paper
• Radiotherapy is Associated With Improved Survival in Patients With Synovial Sarcoma Undergoing Surgery: A National Cancer Database Analysis.

  2020cites this paper
• Heparanase: A Potential Therapeutic Target in Sarcomas.

  2020cites this paper
• Angiosarcoma

  2020cites this paper
• Morphology, structure and cytotoxicity of dye-loaded lipid nanoparticles based on monoamine pillar[5]arenes

  2020cites this paper
• Trofosfamide and Etoposide-A Well Tolerated Palliative Treatment for Adults with Advanced Soft Tissue Sarcoma: A Single Center Experience

  2019cites this paper
• Pathological Features and Clinical Course in Patients With Recurrent or Malignant Orbital Solitary Fibrous Tumor/Hemangiopericytoma.

  2019cites this paper
• Radiation Therapy as Sole Management for Solitary Fibrous Tumors (SFT): A Retrospective Study From the Global SFT Initiative in Collaboration With the Sarcoma Patients EuroNet.

  2018cites this paper
• Tumor-targeting Salmonella typhimurium A1-R is a highly effective general therapeutic for undifferentiated soft tissue sarcoma patient-derived orthotopic xenograft nude-mouse models.

  2018cites this paper
• Primary leiomyosarcoma of the fallopian tube

  2018cites this paper
• The Non-rhabdomyosarcoma Soft Tissue Sarcomas, Desmoid Tumor and Osteosarcoma

  2018cites this paper
• Neoadjuvant and adjuvant strategies in retroperitoneal sarcoma.

  2018cites this paper
• Temozolomide regresses a doxorubicin‐resistant undifferentiated spindle‐cell sarcoma patient‐derived orthotopic xenograft (PDOX): precision‐oncology nude‐mouse model matching the patient with effective therapy

  2018cites this paper
• ESTABLISHMENT AND CHARACTERIZATION OF A PATIENT-DERIVED CANCER MODEL OF UNDIFFERENTIATED PLEOMORPHIC SARCOMA

  2018cites this paper
• A Case of a Subcutaneous Solitary Fibrous Tumor Metastasized to the Liver and Kidney 11 Years after Surgery

  2017cites this paper
• Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy

  2017cites this paper
• High Efficacy of Pazopanib on an Undifferentiated Spindle‐Cell Sarcoma Resistant to First‐Line Therapy Is Identified With a Patient‐Derived Orthotopic Xenograft (PDOX) Nude Mouse Model

  2017influential citation
• Comparison of doxorubicin–cyclophosphamide with doxorubicin–dacarbazine for the adjuvant treatment of canine hemangiosarcoma

  2017cites this paper
• An Update on Non-extremity Soft Tissue Sarcomas.

  2017cites this paper
• Intensive fibrosarcoma-binding capability of the reconstituted analog and its antitumor activity

  2017cites this paper
• Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications

  2017cites this paper
• Immune Therapy for Sarcomas.

  2017cites this paper
• Surgery of Soft Tissue Limb Sarcomas in An African Cancer Center

  2017cites this paper
• An analysis of clinical characteristics and patient outcomes in primary mediastinal sarcomas

  2017cites this paper
• Neoadjuvant treatment: a novel standard?

  2017cites this paper
• First- and second-line systemic treatments for metastatic and locally advanced soft tissue sarcomas in adults

  2016cites this paper
• Uterine sarcoma part III-Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review.

  2016cites this paper
• EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen

  2016cites this paper
• Local Ablative Therapies to Metastatic Soft Tissue Sarcoma.

  2016cites this paper
• Management of Recurrent Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach from the Trans-Atlantic RPS Working Group

  2016cites this paper
• Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons

  2016cites this paper
• Xenograft models for undifferentiated pleomorphic sarcoma not otherwise specified are essential for preclinical testing of therapeutic agents.

  2016cites this paper
• The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas.

  2016cites this paper
• UK guidelines for the management of soft tissue sarcomas

  2016cites this paper
• O PAPEL DA TRABECTEDINA NOS SARCOMAS

  2015cites this paper
• Chest wall tumors: Diagnosis, treatment and reconstruction.

  2015cites this paper
• Inhibidores de la vía Wnt como posible terapia antitumoral en sarcomas

  2015cites this paper
• Leiomyosarcoma of the Hand

  2015cites this paper
• A translocation t(6;14) in two cases of leiomyosarcoma: Molecular cytogenetic and array-based comparative genomic hybridization characterization.

  2015cites this paper
• Dedifferentiated Liposarcoma of the Gastroesophageal Junction.

  2015cites this paper
• Current approaches to cutaneous sarcomas: Dermatofibrosarcoma protuberans and cutaneous leiomyosarcoma.

  2015cites this paper
• Personalizing surgical margins in retroperitoneal sarcomas

  2015cites this paper
• Massive parallel sequencing in sarcoma pathobiology: state of the art and perspectives

  2015cites this paper
• Small bowel sarcoma: Tumor biology and advances in therapeutics.

  2015cites this paper
• Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma

  2015cites this paper
• Dermatofibrosarcoma protuberans: revisión bibliográfica Dermatofibrosarcoma Protuberans: A Review

  2015cites this paper
• Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS

  2015cites this paper
• Intravoxel Incoherent Motion MR Imaging: Comparison of Diffusion and Perfusion Characteristics for Differential Diagnosis of Soft Tissue Tumors

  2015cites this paper
• The Hippo signal transduction pathway in soft tissue sarcomas.

  2015cites this paper
• Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: A Consensus Approach From the Trans-Atlantic RPS Working Group

  2014cites this paper
• Soft tissue limb and trunk sarcomas: diagnosis, treatment and follow-up.

  2014cites this paper
• Dedifferentiated Liposarcoma of the Gastroesophageal Junction Gastroözofageal Bileşke Yerleşimli Dediferansiye Liposarkom

  2014cites this paper